Anti-CPXV vCCI Polyclonal Antibody from ProteoGenix; catalogue ARO-A22258; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-CPXV vCCI Polyclonal Antibody is a powerful tool for researchers in the biotech field. This antibody specifically targets the CPXV vCCI protein, making it an essential addition to any laboratory’s arsenal.
The biological function of this antibody is to bind to the CPXV vCCI protein and inhibit its activity. This protein is known to play a crucial role in the immune evasion of the virus, making it a prime target for research and drug development.
One of the main applications of the Anti-CPXV vCCI Polyclonal Antibody is in the study of poxviruses, specifically cowpox virus (CPXV). This antibody has been extensively validated and has been shown to effectively neutralize CPXV vCCI in various experimental settings.
In addition to its use in basic research, this antibody has also shown promise in therapeutic applications. By targeting the CPXV vCCI protein, it has the potential to disrupt the virus’s ability to evade the host’s immune system, making it a potential candidate for antiviral treatments.
The Anti-CPXV vCCI Polyclonal Antibody has been successfully used in a variety of experimental use cases. These include Western blotting, immunofluorescence, and immunoprecipitation. Its high specificity and sensitivity make it a valuable tool for detecting and quantifying CPXV vCCI in various samples.
In summary, the Anti-CPXV vCCI Polyclonal Antibody is a crucial tool for researchers studying poxviruses and their immune evasion mechanisms. Its ability to specifically target and inhibit the CPXV vCCI protein makes it a valuable addition to any laboratory. With its proven efficacy in various experimental settings, this antibody is a must-have for those working in the biotech field. Order now and take your research to the next level.
ProteoGenix catalogue number ARO-A22258. For research use only.
Target: vCCI or CPXV227 protein, vCCI; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| vCCI or CPXV227 protein, vCCI |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
